University of California

The technology behind Mammoth's platform bears a striking resemblance to the CRISPR-based SHERLOCK platform developed by researchers at the Broad Institute.

A lawyer and a scientist say the best result in the CRISPR patent fight would be narrow patents that prevent anyone from controlling downstream innovation.

The newly announced Microbiome Immunity Project seeks to discover links between autoimmune diseases and bacteria in and on the human body.

Investigators identified ties between autism spectrum disorder and mitochondrial haplogroups in mtDNA variant data from nearly 1,000 ASD-affected families.

Under today's deal, all of UC Health's medical centers will work with GeneDx and have access to more than 400 of the firm's tests for rare hereditary disorders. 

The University of California is appealing the recent CRISPR/Cas9 patent decision.

The First Call

The parties involved in the CRISPR patent fight recently held a conference call, Stat News reports.

A California-based research team modified CRISPR/Cas9 to develop a method to track RNA sequences, which they hope will improve disease research. 

Integrated healthcare systems are corralling their resources and capabilities in applying for a shot to enroll volunteers to the national project.

Fight, Fight, Fight!

The USPTO has become involved in the CRISPR-Cas9 patent dispute.

Pages

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.